CYTK vs TGTX
Cytokinetics Inc · TG Therapeutics Inc
Relative return (rebased to 100)
Key stats
| Metric | CYTK | TGTX |
|---|---|---|
| Price | $78.39 | $53.48 |
| Market Cap | $9.75B | $8.19B |
| P/E | — | 18.31 |
| P/B | — | 14.04 |
| P/S | 110.79 | 13.28 |
| ROE | — | 76.7% |
| Net Margin | -891.6% | 72.6% |
| Gross Margin | — | — |
| Revenue Growth | 376.6% | 87.3% |
| Dividend Yield | — | — |
| EPS | -$6.31 | $2.92 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.